Hebrew University of Jerusalem

GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

Retrieved on: 
Tuesday, February 27, 2024

Professor Tal Burstyn-Cohen, Ph.D. of the Hebrew University, through the Yissum Research Development Company, led the preclinical study.

Key Points: 
  • Professor Tal Burstyn-Cohen, Ph.D. of the Hebrew University, through the Yissum Research Development Company, led the preclinical study.
  • The preclinical study aimed to assess the impact of various combinations of the neuroprotective therapeutic in a preclinical model.
  • “We are excited to finally receive the positive results from our preclinical study, which was our first step in validating our novel, cannabinoid based therapeutic,” said Aitan Zacharin, GCANRx CEO.
  • To receive the latest information about GCANRx sign up to the investor email at https://bit.ly/2ZNlBoj or follow @GCANRX on Twitter.

Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

Retrieved on: 
Tuesday, March 5, 2024

The Lundbeck Foundation has announced the recipients of The Brain Prize 2024, the world’s largest award for outstanding contributions to neuroscience.

Key Points: 
  • The Lundbeck Foundation has announced the recipients of The Brain Prize 2024, the world’s largest award for outstanding contributions to neuroscience.
  • View the full release here: https://www.businesswire.com/news/home/20240305504553/en/
    Theoretical and computational neuroscience permeates neuroscience today and is of increasingly growing importance.
  • The Brain Prize 2024 worth DKK 10 million (€1.3 million) is awarded to:
    Larry Abbott (USA), Terrence Sejnowski (USA), and Haim Sompolinsky (Israel/USA) for their Foundational work in Computational and Theoretical Neuroscience.
  • Chair of The Brain Prize Selection Committee, Professor Richard Morris, explains the reasoning behind this year’s award:
    “It is inconceivable to imagine modern brain sciences without the concomitant development of computational and theoretical neuroscience.

ATCC and Tissue Dynamics Announce a Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market

Retrieved on: 
Tuesday, February 27, 2024

The collaboration will be done under the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD) framework, which awarded both companies a two-year grant.

Key Points: 
  • The collaboration will be done under the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD) framework, which awarded both companies a two-year grant.
  • The BIRD Foundation, established in 1977, bolsters transformative partnerships that stimulate, promote, and support industrial research and development in a wide range of technology sectors.
  • Tissue Dynamics partnered with the Hebrew University of Jerusalem to develop the world’s first mature self-paced multi-chambered cardiac organoid model , using ATCC cells, that emulates critical aspects of human physiology.
  • Tissue Dynamics’ partnership with ATCC aims to advance this cardiac organoid model for industrial use.

BBT.live Expands Seed Funding to $9.5 Million to Enhance Secured Connectivity Services for Service Providers

Retrieved on: 
Wednesday, February 28, 2024

BBT.live proudly announces the expansion of its seed funding round to a total of $9.5 million.

Key Points: 
  • BBT.live proudly announces the expansion of its seed funding round to a total of $9.5 million.
  • Leading this expansion is Tzvi Neta, a dedicated existing investor with a total investment of $5.5 million, reaffirming support for BeBroadband™ as a Service, the secured connectivity subscription solution.
  • This comprehensive platform encompasses Secure Access Service Edge (SASE) cybersecurity, Zero Trust Network Access (ZTNA)/Secure Service Edge (SSE), multi-WAN connectivity, WAN optimization and Solution Orchestration through a user-friendly multi-tenant self-service portal.
  • Tzvi Neta, owner and chairman of Automotive Equipment Group (AEV), leads the seed extension investment, bringing his total investment in BBT.live to $5.5 million.

nT-Tao Compact Fusion Energy Welcomes Dr. Eyal Hulata, Former Israeli National Security Advisor, to its Strategic Advisory Board

Retrieved on: 
Tuesday, February 27, 2024

TEL AVIV, Israel, Feb. 27, 2024 /PRNewswire/ -- nT-Tao, the compact fusion energy company setting a new standard for the future of clean energy, today announced that Dr. Eyal Hulata has joined its Strategic Advisory Board. As the former head of the Israeli National Security Council, Eyal brings decades of national security experience and a strategic global outlook to nT-Tao as the company continues its mission of developing and commercializing a compact fusion energy solution.

Key Points: 
  • As the former head of the Israeli National Security Council, Eyal brings decades of national security experience and a strategic global outlook to nT-Tao as the company continues its mission of developing and commercializing a compact fusion energy solution.
  • Dr. Eyal Hulata is a distinguished figure in Israeli national security and intelligence, with a deep background that spans over two decades.
  • He recently served as Israel's National Security Advisor and Head of the National Security Council under Prime Ministers Naftali Bennett and Yair Lapid.
  • "I am honored to be joining the advisory board of nT-Tao, Israel's first and only nuclear fusion energy company," said Dr. Eyal Hulata.

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

Retrieved on: 
Tuesday, February 13, 2024

JERUSALEM, Feb. 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as Head of Business Development and Sales.

Key Points: 
  • JERUSALEM, Feb. 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as Head of Business Development and Sales.
  • Scinai's broad pharmaceutical development experience, along with its end-to-end biologics drug development and GMP manufacturing facility, drove the Q3 2023 launch of Scinai Bioservices, a boutique end-to-end CDMO business unit, to assist biotech companies efficiently bring their products to market.
  • In addition to expanding the CDMO's business development and sales activities, Halpert will support partnering and out-licensing activities with mid and large cap pharma companies with which Scinai plans on bringing the NanoAbs through clinical trials and towards commercialization.
  • Halpert commented, "I am thrilled to join Scinai where I'll be leading business development and sales of our state-of-the-art end-to-end CDMO services in the global biotech arena.

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

Retrieved on: 
Monday, February 12, 2024

“In the third quarter of fiscal year 2024, we reported solid sequential revenue growth of more than 60% compared with the second quarter.

Key Points: 
  • “In the third quarter of fiscal year 2024, we reported solid sequential revenue growth of more than 60% compared with the second quarter.
  • This increasing demand for our current LungFit PH system was seen even as we prepared to launch a key software update.
  • As our inventory of upgraded LungFit PH grows, we expect to be able to meet accelerating demand over the next several quarters.
  • General and administrative expenses for the three months ended December 31, 2023 and December 31, 2022 were $9.8 million and $8.9 million, respectively.

CTERA’s Michael Amselem is Named a 2024 CRN® Channel Chief

Retrieved on: 
Monday, February 5, 2024

New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- CTERA , the leader in edge-to-cloud file services today announced that CRN ®, a brand of The Channel Company , has named Michael Amselem, Chief Revenue Officer to the prestigious 2024 CRN® Channel Chiefs list, which recognizes IT vendor and distribution executives who are driving strategy and setting the channel agenda for their companies.

Key Points: 
  • New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- CTERA , the leader in edge-to-cloud file services today announced that CRN ®, a brand of The Channel Company , has named Michael Amselem, Chief Revenue Officer to the prestigious 2024 CRN® Channel Chiefs list, which recognizes IT vendor and distribution executives who are driving strategy and setting the channel agenda for their companies.
  • Amselem has over 20 years of experience in enterprise and channel sales and holds a BA in Economy from the Hebrew University in Jerusalem.
  • The Channel Company is pleased to acknowledge these prominent channel leaders and looks forward to chronicling their achievements throughout the year.”
    CTERA appointed Amselem to the CRO post in March 2023.
  • “Congratulations to Michael on making the 2024 CRN Channel Chiefs list,” said Oded Nagel, CEO of CTERA.

Press release - Holocaust Remembrance Day: “Hitler did not win!”

Retrieved on: 
Sunday, February 4, 2024

On Thursday, Irene Shashar, a survivor of the Warsaw ghetto, addressed MEPs in a plenary session in Brussels to commemorate International Holocaust Remembrance Day.

Key Points: 
  • On Thursday, Irene Shashar, a survivor of the Warsaw ghetto, addressed MEPs in a plenary session in Brussels to commemorate International Holocaust Remembrance Day.
  • “We pay tribute today to the victims of the Holocaust and reaffirm our unwavering commitment against antisemitism, racism and other forms of hate.
  • Living in Israel today, she said, “I was blessed with the opportunity to have children and grandchildren.
  • After 7 October “the resurgence of antisemitism means that the hate of the past is still with us”, Ms Shashar warned.

Vintage Investment Partners Announces Two New Members of Its Strategic Advisory Board

Retrieved on: 
Tuesday, January 30, 2024

Dr. Haj-Yehia served between 2019-2023 as Executive Group Chairman of Bank Leumi, the largest and oldest bank in Israel.

Key Points: 
  • Dr. Haj-Yehia served between 2019-2023 as Executive Group Chairman of Bank Leumi, the largest and oldest bank in Israel.
  • "I am thrilled to have Samer and Andy join our Strategic Advisory Board.
  • More importantly, both bring unique experience and perspectives to Vintage that we are thrilled to tap", said Alan Feld, Founder and Co-Managing Partner of Vintage.
  • The other members of the Vintage SAB include: Bradley Bloom, Former Chairman and Co-Founder of Berkshire Partners, Mark Dubowitz, CEO, Foundation for the Defense of Democracies, Ambassador S. Fitzgerald Haney, Former U.S.